Advertisement

Moderna Tumbles After The FDA Throws A Curveball On Its Second Product

Moderna Tumbles After The FDA Throws A Curveball On Its Second Product

Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.